ProposalCENTRAL

This Web-based program was developed in conjunction with 43 private granting foundations. The cost for these granting agencies to design an application through ProposalCENTRAL can range from about $15,000 to $150,000 per granting agency. It's free to users, however, who submitted 9,300 applications through ProposalCENTRAL in 2007. /2008/4/1/93/1/ Click to Submit no

Written byAndrea Gawrylewski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

This Web-based program was developed in conjunction with 43 private granting foundations. The cost for these granting agencies to design an application through ProposalCENTRAL can range from about $15,000 to $150,000 per granting agency. It's free to users, however, who submitted 9,300 applications through ProposalCENTRAL in 2007.

Fewer trees: This application submission tool bypasses the paper application and review process that has clogged private agencies for years. Like Cayuse, once you create a profile on ProposalCENTRAL, it can apply your basic information to any application you work on.

Application hub: Researchers can sign in and access the multiple grant applications they may be working on, track application status, and look at past awards. Most applications share a similar format, and many of the biomedical granting organizations model their applications after the NIH application.

Reviewing pleasure: Researchers who review foundation grants, in addition to submitting their own, use the same ProposalCENTRAL ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies